Detecting epigenetic signature may help people stay ahead of inflammatory bowel disease

September 20, 2018, Cincinnati Children's Hospital Medical Center
This confocal microscopic image from researchers at Cincinnati Children's shows epithelial cells lining the intestine of a mouse. They report in the journal JCI Insights finding an epigenetic signature in patient cells and mouse models that appears to predict inflammation risk in a serious type of inflammatory bowel disease (IBD) called Crohn's disease. With about 1.6 million people in the US dealing with IBD, the findings may help lead to improved diagnosis and treatment for patients. Credit: Cincinnati Children's

With an estimated 1.6 million people in the U.S. dealing with inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report in the journal JCI Insights finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn's disease.

Epigenetics is the study of external modifications to DNA and associated proteins that results in genes being switched "on" or "off" in . In the case of IBD, inflammation may be primed by microbes in the intestine that trigger epigenetics and make people prone to disease, according to researchers at Cincinnati Children's Hospital Medical Center.

The study was performed in donated by newly diagnosed IBD prior to treatment and in laboratory mouse models. The work provides additional insight about the importance of the body's microbiota—the collection of all the microbes (bacteria, fungi, and viruses) that live in our intestines. Increasing evidence has shown important links between the intestinal microbiota and chronic inflammatory diseases.

"This study suggests that the microbiome triggers epigenetic change that could make some individuals more prone to intestinal inflammation," said principal investigator Theresa Alenghat, VMD, Ph.D., Division of Immunobiology. "Each person's microbiome is driven by genetics as well as external environmental factors, such as food, where we live, pets, mom's microbiome, etc."

Conducted by a multi-disciplinary research team of scientists and physicians, the basic science and translational data in the study could lead to development of new diagnostics. This includes methods to predict which newly diagnosed patients are at higher risk of severe disease. It also could provide clues to better therapeutic treatments for IBD.

Histone Methylation

Histones are proteins found in the nucleus of cells. They bind with our DNA and help regulate cell function. Methylation of histones is one process by which epigenetic programs can turn genes on or off. The researchers found several genes with changes in methylation in the nucleus of intestinal cells from newly diagnosed IBD patients. They then used mouse models to determine which of these changes can be influenced by microbiota.

Further analysis of cells showed that changes to histone methylation affected genes involved in immune regulation, metabolism, cell survival and cell signaling. A substantial portion of the genes exhibited levels of histone methylation associated with the severity of inflammation in IBD.

The researchers call their data "clinically relevant." By defining an epigenetic signature in intestinal epithelial cells of newly diagnosed, untreated pediatric IBD patients, the study revealed previously unrecognized pathways that may be altered early in IBD. These pathway could present novel molecular targets for diagnostic evaluation and therapy.

Alenghat said additional research is needed to understand more about how these pathways work during the onset of IBD. Future research efforts will involve work in mouse models of IBD, patient samples and human intestinal organoids—miniature human tissues generated in a laboratory using stem cells derived from patient cells. These steps should allow researchers to uncover the different biological processes that drive this epigenetic signature.

Explore further: How good bacteria can help keep a gut healthy

Related Stories

How good bacteria can help keep a gut healthy

July 3, 2018
New research reveals a cellular mechanism by which good bacteria can help the gut stay healthy. The study, which appears in the journal Immunity, shows that good bacteria, or the microbiota, interact with both the epithelial ...

Your gut development during infancy can have lifelong implications

September 29, 2015
The suckling period (infancy) in mice is critical for epigenetic changes (changes that affect the way genes are expressed) in the development of stem cells in the intestine, potentially affecting intestinal health for life. ...

New therapeutic targets for tumours associated with chronic inflammation

July 11, 2018
Scientists headed by ICREA researcher Angel R. Nebreda at the Institute for Research in Biomedicine (IRB Barcelona) report a new mechanism that contributes to the development of inflammation-associated colon cancer and points ...

Asthmatics show DNA changes in immune cells

February 26, 2018
Children with asthma have epigenetic DNA changes in certain cells of their immune system, a major international study involving researchers at Karolinska Institutet shows. The finding, which is presented in The Lancet Respiratory ...

Zebrafish reveal secrets of the developing gut

July 27, 2017
Our intestine is a highly complex organ – a tortuous, rugged channel built of many specialized cell-types and coated with a protective, slimy matrix. Yet the intestine begins as a simple tube consisting of a central lumen ...

Epigenetic discovery suggests DNA modifications more diverse than previously thought

December 21, 2015
The world of epigenetics—where molecular 'switches' attached to DNA turn genes on and off—has just got bigger with the discovery by a team of scientists from the University of Cambridge of a new type of epigenetic modification.

Recommended for you

Some brain tumors may respond to immunotherapy, new study suggests

December 10, 2018
Immunotherapy has proved effective in treating a number of cancers, but brain tumors have remained stubbornly resistant. Now, a new study suggests that a slow-growing brain tumor arising in patients affected by neurofibromatosis ...

A code for reprogramming immune sentinels

December 10, 2018
For the first time, a research team at Lund University in Sweden has successfully reprogrammed mouse and human skin cells into immune cells called dendritic cells. The process is quick and effective, representing a pioneering ...

Major breakthrough in quest for cancer vaccine

December 6, 2018
The idea of a cancer vaccine is something researchers have been working on for over 50 years, but until recently they were never able to prove exactly how such a vaccine would work.

Newly identified T cells could play a role in cancer and other diseases

December 6, 2018
Researchers from the UCLA Jonsson Comprehensive Cancer Center and the La Jolla Institute for Immunology have identified a new type of T cell called a phospholipid-reactive T cell that is able to recognize phospholipids, the ...

Classifying brain microglia: Which are good and which are bad?

December 6, 2018
Microglia are known to be important to brain function. The immune cells have been found to protect the brain from injury and infection and are critical during brain development, helping circuits wire properly. They also seem ...

Memory B cells in the lung may be important for more effective influenza vaccinations

December 5, 2018
Seasonal influenza vaccines are typically less than 50 percent effective, according to Centers for Disease Control and Prevention studies. Research at the University of Alabama at Birmingham, published this week in Nature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.